cetirizine has been researched along with eszopiclone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Choi, P; Gellad, WF; Good, CB; Kesselheim, AS; Mizah, M | 1 |
1 review(s) available for cetirizine and eszopiclone
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for cetirizine and eszopiclone
Article | Year |
---|---|
Assessing the chiral switch: approval and use of single-enantiomer drugs, 2001 to 2011.
Topics: Antidotes; Azabicyclo Compounds; Benzhydryl Compounds; Bronchodilator Agents; Central Nervous System Stimulants; Cetirizine; Dexlansoprazole; Dexmethylphenidate Hydrochloride; Drug Approval; Drug Prescriptions; Drugs, Generic; Esomeprazole; Eszopiclone; Ethanolamines; Formoterol Fumarate; Histamine H1 Antagonists, Non-Sedating; Humans; Hypnotics and Sedatives; Levoleucovorin; Medicaid; Modafinil; Patents as Topic; Piperazines; Proton Pump Inhibitors; Retrospective Studies; Stereoisomerism; United States; United States Food and Drug Administration; Wakefulness-Promoting Agents | 2014 |